The response to neoadjuvant chemotherapy and prognosis of triple-negative breast cancer patients.

被引：0
|
作者：
Nakano, E. [1 ]
Hojo, T. [1 ]
Masumura, K. [1 ]
Kikuyama, M. [1 ]
Akashi, S. [1 ]
Kinoshita, T. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo 104, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：337S / 337S
页数：1
相关论文
共 50 条
  • [1] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Wu, Jiannan
    Li, Shunrong
    Jia, Weijuan
    Su, Fengxi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1505 - 1510
  • [2] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    [J]. Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [3] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    [J]. CANCER RESEARCH, 2015, 75
  • [4] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    [J]. PLOS ONE, 2016, 11 (12):
  • [5] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Masuda, Hiroko
    Masuda, Norikazu
    Kodama, Yoshinori
    Ogawa, Masami
    Karita, Michiko
    Yamamura, Jun
    Tsukuda, Kazunori
    Doihara, Hiroyoshi
    Miyoshi, Shinichiro
    Mano, Masayuki
    Nakamori, Shoji
    Tsujinaka, Toshimasa
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 911 - 917
  • [6] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Hiroko Masuda
    Norikazu Masuda
    Yoshinori Kodama
    Masami Ogawa
    Michiko Karita
    Jun Yamamura
    Kazunori Tsukuda
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Masayuki Mano
    Shoji Nakamori
    Toshimasa Tsujinaka
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 911 - 917
  • [7] BRCAness and prognosis of triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
    Akashi-Tanaka, Sadako
    Tanino, Yuichi
    Yamamoto, Yutaka
    Nishimiya, Hiroshi
    Yamamoto-ibusuki, Mutsuko
    Iwase, Hirotaka
    Nakamura, Seigo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] TOPK: A new predictor of the therapeutic response to neoadjuvant chemotherapy and prognosis in triple-negative breast cancer
    Wang, Kaijing
    Chai, Jia
    Xu, Junpeng
    Wei, Jie
    Li, Peifeng
    Liu, Yixiong
    Ma, Jing
    Xu, Tianqi
    Zhao, Danhui
    Yu, Kangjie
    Fan, Linni
    Yan, Qingguo
    Guo, Shuangping
    Li, Mingyang
    Wang, Zhe
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2021, 226
  • [9] Comparison of the effectiveness of neoadjuvant chemotherapy and adjuvant chemotherapy for improving prognosis in triple-negative breast cancer patients
    Li, Wangbin
    Chang, Yuwei
    Bai, Xiaohui
    Cao, Hongxin
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3978 - 3989
  • [10] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    [J]. BIOSCIENCE REPORTS, 2019, 39
12345